Hepatitis D virus: Introduction and epidemiology

Cold Spring Harbor Perspectives in Medicine

Volumn 5, Issue 7, 2015, Pages 1-10

  Rizzetto, Mario ^a  

^a UNIVERSITY OF TURIN   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; DELTA AGENT HEPATITIS; ENDEMIC DISEASE; EUROPE; GENOTYPE; HEPATITIS DELTA VIRUS; HUMAN; NONHUMAN; PREVALENCE; BLOOD; DRUG USE; GENETICS; HEPATITIS B VIRUS; HEPATITIS D; SUPERINFECTION;

HEPATITIS B VIRUS; HEPATITIS DELTA VIRUS;

HEPATITIS B SURFACE ANTIGEN;

DRUG USERS; EUROPE; HEPATITIS B SURFACE ANTIGENS; HEPATITIS B VIRUS; HEPATITIS D; HEPATITIS DELTA VIRUS; HUMANS; SUPERINFECTION;

EID: 84940035724     PISSN: None     EISSN: 21571422     Source Type: Journal    
DOI: 10.1101/cshperspect.a021576     Document Type: Article

References (63)

1. Reference is also in this collection.
2. Abbas Z, Jafri W, Raza S. 2010. Hepatitis D: Scenario in the Asia-Pacific region. World J Gastroenterol 16: 554-562.
3. Amini N, Alavian SM, Kabir A, Aalaei-Andabili SH, Saiedi Hosseini SY, Rizzetto M. 2013. Prevalence of hepatitis D in the eastern Mediterranean region: Systematic review and meta analysis. Hepat Mon 13: e8210.
4. Arakawa Y, Moriyama M, Taira M, Hayashi N, Tanaka N, Okubo H, Sugitani M. 2000. Molecular analysis of hepatitis D virus infection in Miyako Island, a small Japanese island. J Viral Hepat 7: 375-381.
5. Bahcecioglu IH, Aygun C, Gozel N, Poyrazoglu OK, Bulut Y, Yalniz M. 2011. Prevalence of hepatitis delta virus (HDV) infection in chronic hepatitis B patients in eastern Tur-key: Still a serious problem to consider. J Viral Hepat 18: 518-524.
6. Baig S, Siddiqui AA, Ahmed WU, Qureshi H, Arif A. 2009. Frequency of hepatitis C and D super infection in patients with hepatitis B related complex liver disorders. J Coll Physicians Surg Pak 19: 699-703.
7. Bakhshipour A, Mashhadi M, Mohammadi M, Nezam SK. 2013. Seroprevalence and risk factors of hepatitis delta virus in chronic hepatitis B virus infection in Zahedan. Acta Med Iran 51: 260-264.
8. Bayan K, Yilmaz S, Tuzun Y, Yildirim Y. 2007. Epidemiolog-ical and clinical aspects of liver cirrhosis in adult patients living in Southeastern Anatolia: Leading role of HBV in 505 cases. Hepatogastroenterology 54: 2198-2202.
9. Børresen ML, Olsen OR, Ladefoged K, McMahon BJ, Hjuler T, Panum I, Simonetti J, Jones C, Krarup H, Koch A. 2010. Hepatitis D outbreak among children in a hepatitis B hyper-endemic settlement in Greenland. J Viral Hepat 17: 162-170.
10. Braga WS, Castilho Mda C, Borges FG, Leão JR, Martinho AC, Rodrigues IS, Azevedo EP, Barros Júnior GM, Paraná R. 2012. Hepatitis D virus infection in the Western Bra-zilian Amazon—Far from a vanishing disease. Rev Soc Bras Med Trop 45: 691-695.
11. Brancaccio G, Giuberti T, Verucchi G, Levantesi M, Sacchini D, Fattovich G, Madonia S, Fasano M, Gavrila C, Nardi A, et al. 2014. Epidemiological evolution of chronic hepati-tis delta in Italy. An analysis of the master-B cohort. Dig Liv Dis 46: e12-e13.
12. Buti M, Homs M, Rodriguez-Frias F, Funalleras G, Jardí R, Sauleda S, Tabernero D, Schaper M, Esteban R. 2011. Clinical outcome of acute and chronic hepatitis delta over time: A long-term follow-up study. J Viral Hepat 18: 434-442.
13. Chakraborty P, Kailash U, Jain A, Goyal R, Gupta RK, Das BC, Kar P. 2005. Seroprevalence of hepatitis D virus in patients with hepatitis B virus-related liver diseases. In-dian J Med Res 122: 254-257.
14. Ciancio A, Rizzetto M. 2002. Clinical patterns, epidemiology and disease burden of hepatitis D virus chronic liver disease (ed. Margolis H, Alter M, Liang T, Dienstag J), pp. 271-275. International Medical Press, London.
15. Cross TJ, Rizzi P, Horner M, Jolly A, Hussain MJ, Smith HM, Vergani D, Harrison PM. 2008. The increasing prevalence of hepatitis delta virus (HDV) infection in south London. J Med Virol 80: 277-282.
16. Duraisamy G, Zuridah H, Ariffin Y, Kek CS. 1994. Hepatitis delta virus in intravenous drug users in Kuala Lumpur. Med J Malaysia 49: 212-216.
17. Farci P. 2003. Delta hepatitis: An update. J Hepatol 39: S212-S219.
18. Flodgren E, Bengtsson S, Knutsson M, Strebkova EA, Kidd AH, Alexeyev OA, Kidd-Ljunggren K. 2000. Recent high incidence of fulminant hepatitis in Samara, Russia: Mo-lecular analysis of prevailing hepatitis B and D virus strains. J Clin Microbiol 38: 3311-3316.
19. Foupouapouognigni Y, Noah DN, Sartre MT, Njouom R. 2011. High prevalence and predominance of hepatitis delta virus genotype 1 infection in Cameroon. J Clin Microbiol 49: 1162-1164.
20. Gaeta GB, Stroffolini T, Chiaramonte M, Ascione T, Stor-naiuolo G, Lobello S, Sagnelli E, Brunetto MR, Rizzetto M. 2000. Chronic hepatitis D: A vanishing disease? An Italian multicenter study. Hepatology 32: 824-827.
21. Genné D, Rossi I. 2011. Hepatitis delta in Switzerland: A silent epidemic. Swiss Med Wkly 141: w13176.
22. Gish RG, Yi DH, Kane S, Clark M, Mangahas M, Baqai S, Winters MA, Proudfoot J, Glenn JS. 2013. Coinfection with hepatitis B and D: Epidemiology, prevalence and disease in patients in Northern California. J Gastroenterol Hepatol 28: 1521-1525.
23. Gomaa NI, Metwally LA, Nemr N, Younis S. 2013. Sero-prevalence of HDV infection in HBsAg positive population in Ismailia, Egypt. Egypt J Immunol 20: 23-28.
24. Hadler SC, Alcala de Monzon M, Bensabath G, Martinez Duran M, Schatz G, Fields HA. 1991. Epidemiology of hepatitis delta virus infection in less developed countries. Prog Clin Biol Res 364: 21-31.
25. Holmberg SD, Ward JW. 2010 Hepatitis delta: Seek and ye shall find. J Infect Dis 202: 822-824.
26. Ionescu B, Mihăescu G. 2011. Hepatitis B, C and D coinfec-tion in HIV-infected patients: Prevalence and progress. Roum Arch Microbiol Immunol 70: 129-133.
27. Khan A, Kurbanov F, Tanaka Y, Elkady A, Sugiyama M, Dustov A, Mizokami M. 2008. Epidemiological and clin-ical evaluation of hepatitis B, hepatitis C, and delta hep-atitis viruses in Tajikistan. J Med Virol 80: 268-276.
28. Kim HS, Kim SJ, Park HW, Shin WG, Kim KH, Lee JH, Kim HY, Jang MK. 2011. Prevalence and clinical significance of hepatitis D virus co-infection in patients with chronic hepatitis B in Korea. J Med Virol 83: 1172-1177.
29. Kucirka LM, Farzadegan H, Feld JJ, Mehta SH, Winters M, Glenn JS, Kirk GD, Segev DL, Nelson KE, Marks M, et al. 2010. Prevalence, correlates, and viral dynamics of hep-atitis delta among injection drug users. J Infect Dis 202: 845-852.
30. Le Gal F, Gault E, Ripault MP, Serpaggi J, Trinchet JC, Gor-dien E, Dény P. 2006. Eighth major clade for hepatitis delta virus. Emerg Infect Dis 12: 1447-1450.
31. Le Gal F, Castelneau C, Gault E, et al. 2007. Hepatitis D virus infection. Not a vanishing disease in Europe! Hepatology 45: 1332-1333.
32. Li J, Wang J, Tian K, Wang Y, Zhang L, Huang H. 2006. Epidemiology of hepatitis B, C, D and G viruses and cytokine levels among intravenous drug users. J Hua-zhong Univ Sci Technolog Med Sci 26: 221-224.
33. Makuwa M, Mintsa-Ndong A, Souquière S, Nkoghé D, Leroy EM, Kazanji M. 2009. Prevalence and molecular di-versity of hepatitis B virus and hepatitis delta virus in urban and rural populations in northern Gabon in cen-tral Africa. J Clin Microbiol 47: 2265-2268.
34. Mansour W, Malick FZ, Sidiya A, Ishagh E, Chekaraou MA, Veillon P, Ducancelle A, Brichler S, Le Gal F, Lo B, et al. 2012. Prevalence, risk factors, and molecular epidemiol-ogy of hepatitis B and hepatitis delta virus in pregnant women and in patients in Mauritania. J Med Virol 84: 1186-1198.
35. Moatter T, Abbas Z, Shabir S, Jafri W. 2007. Clinical presen-tation and genotype of hepatitis delta in Karachi. World J Gastroenterol 13: 2604-2607.
36. Murhekar MV, Murhekar KM, Arankalle VA, Sehgal SC. 2005. Hepatitis delta virus infection among the tribes of the Andaman and Nicobar Islands, India. Trans R Soc Trop Med Hyg 99: 483-484.
37. Negro F. 2014. Structure and molecular virology. In Viral hepatitis, 4th ed. (ed. Thomas HC, Lok ASF, Locarnini SA, Zuckerman AJ), pp. 395-402. Wiley, Blackwell.
38. Nwokediuko SC, Ijeoma U. 2009. Seroprevalence of antibody to HDV in Nigerians with hepatitis B virus-related liver diseases. Niger J Clin Pract 12: 439-442.
39. Ponzetto A, Negro F, Popper H, Bonino F, Engle R, Rizzetto M, Purcell RH, Gerin JL. 1988. Serial passage of hepatitis delta virus in chronic hepatitis B virus carrier chimpan-zees. Hepatology 8: 1655-1661.
40. Popescu GA, Otelea D, Gavriliu LC, Neaga E, Popescu C, Paraschiv S, Fratila M. 2013. Epidemiology of hepatitis D in patients infected with hepatitis B virus in Bucharest: A cross-sectional study. J Med Virol 85: 769-774.
41. Quaglio G, Ramadani N, Pattaro C, Cami A, Dentico P, Volpe A, Pellizzer G, Berisha A, Smacchia C, Figliomeni M, et al. 2008. Prevalence and risk factors for viral hep-atitis in the Kosovarian population: Implications for health policy. J Med Virol 80: 833-840.
42. Rizzetto M. 1983. The delta agent. Hepatology 3: 729-737.
43. Rizzetto M. 2009. Hepatitis D: Thirty years after. J Hepatol 50: 1043-1050.
44. Rizzetto M, Alavian SM. 2013. Hepatitis delta: The redis-covery. Clin Liver Dis 17: 475-487.
45. Rizzetto M, Ciancio A. 2012. Epidemiology of hepatitis D. Semin Liver Dis 32: 211-219.
46. Rizzetto M, Canese MG, Aricò S, Crivelli O, Trepo C, Bo-nino F, Verme G. 1977. Immunofluorescence detection of new antigen-antibody system (delta/anti-delta) associat-ed to hepatitis B virus in liver and in serum of HBsAg carriers. Gut 18: 997-1003.
47. Rizzetto M, Ponzetto A, Forzani I. 1990. Hepatitis delta virus as a global health problem. Vaccine 8: S10-S14; discussion S21-S23.
48. Rizzetto M, Ponzetto A, Forzani I. 1991. Epidemiology of hepatitis delta virus: Overview. Prog Clin Biol Res 364: 1-20.
49. Rosina F, Conoscitore P, Cuppone R, Rocca G, Giuliani A, Cozzolongo R, Niro G, Smedile A, Saracco G, Andriulli A, et al. 1999. Changing pattern of chronic hepatitis D in Southern Europe. Gastroenterology 117: 161-166.
50. Sagnelli E, Stroffolini T, Ascione A, Bonino F, Chiaramonte M, Colombo M, Craxi A, Giusti G, Manghisi OG, Pastore G, et al. 1992. The epidemiology of hepatitis delta infec-tion in Italy. J Hepatol 15: 211-215.
51. Saravanan S, Velu V, Kumarasamy N, Shankar EM, Nanda-kumar S, Murugavel KG, Balakrishnan P, Solomon S, Thyagarajan SP. 2008. Seroprevalence of hepatitis delta virus infection among subjects with underlying hepatic diseases in Chennai, southern India. Trans R Soc Trop Med Hyg 102: 793-796.
52. Servant-Delmas A, Le Gal F, Gallian P, Gordien E, Laperche S. 2014. Increasing prevalence of HDV/HBV infection over 15 years in France. J Clin Virol 59: 126-128.
53. Shaikh MA, Shaikh WM, Solangi GA, Shaikh BA, Soomro MA. 2011. Frequency of hepatitis D virus infection in hepatitis B surface antigen-positive liver diseases. J Coll Physicians Surg Pak 21: 23-25.
54. Smedile A, Rizzetto M, Gerin JL. 1994. Advances in hepatitis D virus biology and disease. Prog Liver Dis 12: 157-175.
55. Soriano V, Grint D, d’Arminio Monforte A, Horban A, Leen C, Poveda E, Antunes F, de Wit S, Lundgren J, Rockstroh J, et al. 2011. Hepatitis delta in HIV-infected individuals in Europe. AIDS 25: 1987-1992.
56. Stroffolini T, Almasio PL, Sagnelli E, Mele A, Gaeta GB; Italian Hospitals’ Collaborating Group. 2009. Evolving clinical landscape of chronic hepatitis B: A multicenter Italian study. J Med Virol 81: 1999-2006.
57. Sy BT, Ratsch BA, Toan NL, Song le H, Wollboldt C, Bryniok A, Nguyen HM, Luong HV, Velavan TP, Wedemeyer H, et al. 2013. High prevalence and significance of hepatitis D virus infection among treatment-naïve HBsAg-positive patients in Northern Vietnam. PLoS ONE 8: e78094.
58. Taylor JM. 2015. Hepatitis D virus replication. Cold Spring Harb Perspect Med doi: 10.1101/cshperspect.a021568.
59. Theamboonlers A, Hansurabhanon T, Verachai V, Chongsrisawat V, Poovorawan Y. 2002. Hepatitis D virus infec-tion in Thailand: HDV genotyping by RT-PCR, RFLP and direct sequencing. Infection 30: 140-144.
60. Tsatsralt-Od B, Takahashi M, Endo K, Buyankhuu O, Baatarkhuu O, Nishizawa T, Okamoto H. 2006. Infection with hepatitis A, B, C, and delta viruses among patients with acute hepatitis in Mongolia. J Med Virol 78: 542-550.
61. Wedemeyer H, Manns MP. 2010. Epidemiology, pathogenesis and management of hepatitis D: Update and chal-lenges ahead. Nat Rev Gastroenterol Hepatol 7: 31-40.
62. Zaidi G, Idrees M, Malik FA, Amin I, Shahid M, Younas S, Hussain R, Awan Z, Tariq A, Parveen K. 2010. Prevalence of hepatitis delta virus infection among hepatitis B virus surface antigen positive patients circulating in the largest province of Pakistan. Virol J 26: 283.
63. Ziaee M, Azarkar G. 2013. Prevalence of hepatitis d virus infection among patients with chronic hepatitis B attending birjand hepatitis clinic (East of Iran) in 2012. Hepat Mon 13: e11168.